444 related articles for article (PubMed ID: 2789253)
1. Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase.
Messina JP; Lawrence DA
J Immunol; 1989 Sep; 143(6):1974-81. PubMed ID: 2789253
[TBL] [Abstract][Full Text] [Related]
2. Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function.
Smyth MJ
J Immunol; 1991 Mar; 146(6):1921-7. PubMed ID: 2005386
[TBL] [Abstract][Full Text] [Related]
3. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation.
Hamilos DL; Wedner HJ
J Immunol; 1985 Oct; 135(4):2740-7. PubMed ID: 4031498
[TBL] [Abstract][Full Text] [Related]
4. Thiol-mediated redox regulation of lymphocyte proliferation. Possible involvement of adult T cell leukemia-derived factor and glutathione in transferrin receptor expression.
Iwata S; Hori T; Sato N; Ueda-Taniguchi Y; Yamabe T; Nakamura H; Masutani H; Yodoi J
J Immunol; 1994 Jun; 152(12):5633-42. PubMed ID: 8207197
[TBL] [Abstract][Full Text] [Related]
5. Glutathione depletion in human T lymphocytes: analysis of activation-associated gene expression and the stress response.
Walsh AC; Michaud SG; Malossi JA; Lawrence DA
Toxicol Appl Pharmacol; 1995 Aug; 133(2):249-61. PubMed ID: 7645021
[TBL] [Abstract][Full Text] [Related]
6. De novo synthesis of glutathione is required for both entry into and progression through the cell cycle.
Poot M; Teubert H; Rabinovitch PS; Kavanagh TJ
J Cell Physiol; 1995 Jun; 163(3):555-60. PubMed ID: 7539813
[TBL] [Abstract][Full Text] [Related]
7. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
Kang YJ
Cell Mol Biol Res; 1995; 41(2):131-6. PubMed ID: 8581064
[TBL] [Abstract][Full Text] [Related]
8. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
Bertsche U; Schorn H
Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
[TBL] [Abstract][Full Text] [Related]
9. Growth-associated modifications of low-molecular-weight thiols and protein sulfhydryls in human bronchial fibroblasts.
Atzori L; Dypbukt JM; Sundqvist K; Cotgreave I; Edman CC; Moldéus P; Grafström RC
J Cell Physiol; 1990 Apr; 143(1):165-71. PubMed ID: 2318904
[TBL] [Abstract][Full Text] [Related]
10. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
[TBL] [Abstract][Full Text] [Related]
11. Increased glutathione levels in quiescent, serum-stimulated NRK-49F cells are associated not with a response to growth factors but with nutrient repletion.
Kang YJ; Enger MD
J Cell Physiol; 1991 Aug; 148(2):197-201. PubMed ID: 1679059
[TBL] [Abstract][Full Text] [Related]
12. Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line.
Armstrong JS; Steinauer KK; Hornung B; Irish JM; Lecane P; Birrell GW; Peehl DM; Knox SJ
Cell Death Differ; 2002 Mar; 9(3):252-63. PubMed ID: 11859408
[TBL] [Abstract][Full Text] [Related]
13. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells.
Yamauchi A; Bloom ET
J Immunol; 1993 Nov; 151(10):5535-44. PubMed ID: 8228244
[TBL] [Abstract][Full Text] [Related]
14. Effects of 2-mercaptoethanol and buthionine sulfoximine on cystine metabolism by and proliferation of mitogen-stimulated human and mouse lymphocytes.
Messina JP; Lawrence DA
Int J Immunopharmacol; 1992 Oct; 14(7):1221-34. PubMed ID: 1452407
[TBL] [Abstract][Full Text] [Related]
15. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
Shrieve DC; Denekamp J; Minchinton AI
Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
[TBL] [Abstract][Full Text] [Related]
16. Glutathione, cell proliferation, and 1,3-bis-(2-chloroethyl)-1-nitrosourea in K562 leukemia.
Frischer H; Kennedy EJ; Chigurupati R; Sivarajan M
J Clin Invest; 1993 Dec; 92(6):2761-7. PubMed ID: 8254030
[TBL] [Abstract][Full Text] [Related]
17. Mercuric chloride down-regulates T cell interferon-gamma production in brown Norway but not in Lewis rats; role of glutathione.
van der Meide PH; de Labie MC; Botman CA; van Bennekom WP; Olsson T; Aten J; Weening JJ
Eur J Immunol; 1993 Mar; 23(3):675-81. PubMed ID: 8449215
[TBL] [Abstract][Full Text] [Related]
18. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture.
Miranda AF; Wiley MJ; Wells PG
Toxicol Appl Pharmacol; 1994 Feb; 124(2):230-41. PubMed ID: 8122268
[TBL] [Abstract][Full Text] [Related]
19. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
[TBL] [Abstract][Full Text] [Related]
20. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
Xu BH; Gupta V; Singh SV
Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]